| ID | Name | CAS |
MW (g/mol) |
| 70-173-2 |
D-(-)-Tagatose, pentakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
| 646.20 |
| 70-155-2 |
D-(-)-Fructose, pentakis(trimethylsilyl) ether, benzyloxime (isomer 2)
|
| 646.20 |
| 41-819-7 |
D-Psicose, pentakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
| 646.20 |
| 23-047-4 |
D-(+)-Talose, pentakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
| 646.20 |
| 39-345-6 |
L-Fucitol, pentakis(trifluoroacetate)
|
| 646.21 |
| 62-162-3 |
Heptadecafluorononanoic acid, tridecyl ester
|
| 646.42 |
| 23-762-0 |
Mercury, (1,4,5,6,7,7-hexachloro-5-norbornene-2,3-dicarboximidato)-phenyl-
|
5834-81-1 | 646.53 |
| 29-110-7 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl acetate
|
| 646.76 |
| 74-608-5 |
Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1)
|
31570-04-4 | 646.92 |
| 48-945-0 |
Trimethyl-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-trimethylsilyloxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]silane
|
| 646.96 |
| 36-031-7 |
Octatriacontyl trifluoroacetate
|
| 647.03 |
| 69-063-6 |
N-Acetylaspartylglutamic acid, tris(tert-butyldimethylsilyl) ester
|
| 647.04 |
| 117-177-6 |
6,7-dehydro-methylprednisolone, diMO-triTMS (1)
|
| 647.08 |
| 123-380-3 |
6,7-dehydro-methylprednisolone, diMO-triTMS (2)
|
| 647.08 |
| 48-859-6 |
Xanthine riboside, TMS
|
| 647.15 |
| 42-975-3 |
Prednisone, tetra-TMS
|
| 647.15 |
| 45-961-5 |
4-Cholestenoic acid, 7-«alpha»-ol-3-one, TMS
|
| 647.16 |
| 70-643-0 |
4-Cholestenoic acid, 7-«beta»-ol-3-one, TMS
|
| 647.16 |
| 67-868-5 |
Tetratriacontane, 2,20-dimethyl
|
| 647.24 |
| 37-776-0 |
Tetratriacontane, 2,24-dimethyl
|
| 647.24 |
| 37-899-4 |
Tetratriacontane, 12,16-dimethyl
|
| 647.24 |
| 37-795-9 |
Tetratriacontane, 10,14-dimethyl
|
| 647.24 |
| 23-683-8 |
Tetratriacontane, 2,22-dimethyl
|
| 647.24 |
| 11-946-9 |
Tetratriacontane, 2,14-dimethyl
|
| 647.24 |
| 51-524-3 |
Tetratriacontane, 11,15-dimethyl
|
| 647.24 |
| 101-066-6 |
Hexatetracontane
|
7098-24-0 | 647.24 |
| 79-950-0 |
11,16-Bis-decyl-hexacosane
|
72936-28-8 | 647.24 |
| 62-492-7 |
2,6-Bis(picrylazo)-3,5-dinitropyridine
|
55106-96-2 | 647.30 |
| 34-829-4 |
D-galactose, TMS diethyldithioacetal derivative
|
| 647.31 |
| 13-297-8 |
D-mannose, TMS diethyldithioacetal derivative
|
| 647.31 |
| 28-952-4 |
D-glucose, TMS diethyldithioacetal derivative
|
| 647.31 |
| 31-300-3 |
N-(1,2-Dimethylpropyl)-N,N-bis(heptafluorobutyryl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
| 647.43 |
| 75-372-6 |
1h,1h-Perfluoro-2,5,8-trimethyl-3,6,9-trioxaundecan-1-ol
|
14620-81-6 | 648.11 |
| 67-498-6 |
THP, TMS
|
| 648.22 |
| 124-002-1 |
Hexanol «beta»-D-glucopyranoside, TFA
|
| 648.35 |
| 117-108-2 |
Hexyl «beta»-D-glucopyranoside, TFA
|
| 648.35 |
| 36-397-2 |
6«alpha»-Methylprednisolone, bis-MO-tris-TMS
|
| 649.10 |
| 61-672-8 |
methylprednisolone, diMO-triTMS (2)
|
| 649.10 |
| 69-777-4 |
methylprednisolone, diMO-triTMS (1)
|
| 649.10 |
| 122-708-0 |
Tris(dimethyl-t-butylsilyl) O-(dimethyl-t-butylsilyl)citrate
|
99477-48-2 | 649.17 |
| 25-032-8 |
Isocitric acid, tetraTBDMS
|
| 649.17 |
| 74-570-7 |
Docosanoic acid, docosyl ester
|
17671-27-1 | 649.17 |
| 113-593-8 |
Prednisolone, tetra-TMS
|
| 649.17 |
| 121-610-9 |
Cortisone, tetra-TMS
|
| 649.17 |
| 41-934-9 |
5-Cholestenoic acid, 3-«beta»,7-«beta»-diol, TMS
|
| 649.18 |
| 24-611-6 |
5-Cholestenoic acid, 3-«beta»,7-«alpha»-diol, TMS
|
| 649.18 |
| 16-779-0 |
Dichlorphen, O,O'-bis(3-Fluoro-4-trifluoromethylbenzoyl)-
|
| 649.31 |
| 73-440-2 |
Benzamide, 3-trifluoromethyl-2-fluoro-N-(3-trifluoromethyl-2-fluorobenzoyl)-N-octadecyl-
|
| 649.70 |
| 77-268-0 |
3-Iodo-L-tyrosine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
| 649.87 |
| 58-397-8 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2,2,2-Trifluoroacetyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate
|
| 650.56 |
| 78-172-5 |
Aluminium-octaethylporphyrine complex, OTMS
|
| 650.95 |
| 83-033-3 |
Di-n-hexadecyl sebacate
|
26719-48-2 | 651.10 |
| 52-550-3 |
Cholest-5-en-3-ol (3«beta»)-, 9-octadecenoate, (Z)-
|
303-43-5 | 651.10 |
| 70-619-7 |
2H-1-Benzopyran, 3,4-dihydro-2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,5,7-tris[(trimethylsilyl)oxy]-, (2R-trans)-
|
64138-54-1 | 651.17 |
| 71-822-0 |
Silane, [[2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triyl]tris(oxy)]tris[trimethyl-, (2R-cis)-
|
89267-68-5 | 651.17 |
| 70-620-5 |
Catechin, penta-TMS
|
| 651.17 |
| 44-746-5 |
cis-Catechin, pentakis-TMS
|
| 651.17 |
| 27-963-3 |
Cortisol enol-TMS
|
| 651.18 |
| 68-401-1 |
Cortisol tetra-TMS
|
| 651.18 |
| 22-828-8 |
N,N'-[Methylenebis(2-chloro-4,1-phenylene)]tetra(2,2,2-trifluoroacetamide)
|
| 651.19 |
| 67-507-5 |
3«alpha»,7«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 651.20 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 651.20 |
| 53-458-5 |
3«alpha»,5«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 651.20 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 651.20 |
| 29-840-7 |
propranolol, HFB
|
| 651.39 |
| 42-648-6 |
Methyl 5-«beta»-cholan-3-«alpha»,12-«alpha»-diol-7-one-24-oate, oxime, TMS
|
| 652.14 |
| 12-325-7 |
Methyl 5-«beta»-cholan-3-«alpha»,7-«alpha»-diol-12-one-24-oate, oxime, TMS
|
| 652.14 |
| 19-548-3 |
Methyl 5-«beta»-cholan-7-«alpha»-12-«alpha»-diol-3-one-24-oate, oxime, TMS
|
| 652.14 |
| 37-350-2 |
Tetrahydrocortisone, MO TMS
|
| 652.14 |
| 63-451-1 |
Benzyl «beta»-D-glucopyranoside, TFA
|
| 652.34 |
| 13-617-2 |
Dirhenium decacarbonyl
|
14285-68-8 | 652.51 |
| 72-278-4 |
Pentadecafluorooctanoic acid, heptadecyl ester
|
| 652.52 |
| 80-679-0 |
P-toluenesulfonamide], n,n'-dithiodiethylenebis[n-(2-thenyl)-
|
103458-90-8 | 652.96 |
| 42-175-1 |
Isoflupredone, bis-MO-tris-TMS
|
| 653.06 |
| 63-925-5 |
Glycerol, 1-(11,12)-cyclopropyl-C17, 2-ai-C15, TMS
|
| 653.10 |
| 83-027-0 |
Cholesteryl stearate
|
35602-69-8 | 653.12 |
| 47-877-7 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy-5«beta»-homocholanoic acid, MeTMS
|
| 653.17 |
| 20-581-4 |
Tetrahydrocortisone enol-TMS
|
| 653.20 |
| 43-015-7 |
3A,17A,21-Trihydroxy-5B-pregnan-11,20-dione, enol, tetrakis-TMS
|
| 653.20 |
| 36-494-4 |
Tetrahydrocortisone tetra-TMS
|
| 653.20 |
| 24-792-6 |
L-(-)-Fucose, tetrakis(trifluoroacetate), benzyloxime (isomer 1)
|
| 653.33 |
| 70-854-6 |
L-(-)-Fucose, tetrakis(trifluoroacetate), benzyloxime (isomer 2)
|
| 653.33 |
| 53-686-2 |
1,8-Diiodoperfluorooctane
|
| 653.87 |
| 58-133-0 |
15(S)-15-Methyl-PGD2, BO-TMS
|
| 654.16 |
| 124-802-3 |
bis(triphenylphosphine)nickel(II) chloride
|
14264-16-5 | 654.17 |
| 70-202-9 |
allo-Tetrahydrocorticosterone, TMSO-TMS # 2
|
| 654.23 |
| 115-811-3 |
5«xi»-Pregnan-11-one, 1«xi»,3«xi»,20«xi»-trihydroxy, TMSO-TMS
|
| 654.23 |
| 124-125-5 |
3,4-Dihydroxy-dl-phenylalanine, N,O,O'-tris(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
| 654.23 |
| 70-004-9 |
Tetrahydrocorticosterone, TMSO-TMS # 1
|
| 654.23 |
| 40-716-2 |
allo-Tetrahydrocorticosterone, TMSO-TMS # 1
|
| 654.23 |
| 70-203-8 |
Tetrahydrocorticosterone, TMSO-TMS # 2
|
| 654.23 |
| 26-831-0 |
Benzenemethanol, Gly, TFA
|
| 654.31 |
| 67-485-0 |
Stearic acid, strontium salt
|
| 654.56 |
| 91-363-8 |
Sebacic acid, heptadecyl 2,2,3,3,4,4,5,5-octafluoropentyl ester
|
| 654.76 |
| 124-403-6 |
Diethylmalonic acid, eicosyl 2,2,3,3,4,4,5,5-octafluoropentyl ester
|
| 654.76 |
| 10-738-1 |
dimercury diiodide
|
15385-57-6 | 654.99 |
| 56-122-4 |
3A,11B,17A,21-Tetrahydroxy-5B-pregnan-20-one, enol, tetrakis-TMS
|
| 655.22 |
| 55-607-7 |
«beta»-Cortolone, tetrakis-TMS
|
| 655.22 |
| 71-341-4 |
Pregnan-11-one, 3,17,20,21-tetrakis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20R)-
|
56196-47-5 | 655.22 |
| 26-412-5 |
Pregnan-11-one, 3,17,20,21-tetrakis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20S)-
|
56196-46-4 | 655.22 |
|
« Previous Results
Next Results »
|